Retatrutide Dosage Calculator
Calculate your retatrutide research dosage, titration schedule, and reconstitution syringe draw volume. Based on published Phase 2 clinical trial data. Includes female-specific considerations.
Titration Schedule
Enter your current week to see the recommended retatrutide dose based on the Phase 2 clinical trial protocol.
Retatrutide Dosage Chart
| Week | Dose | Phase | Notes |
|---|---|---|---|
| 1–4 | 2 mg / week | Initiation | Starting dose to assess tolerance |
| 5–8 | 4 mg / week | Titration 1 | First dose escalation |
| 9–12 | 8 mg / week | Titration 2 | Second dose escalation |
| 13+ | 12 mg / week | Target dose | Maximum recommended research dose |
Clinical Trial Results
| Dose Group | Weight Loss | % Lost ≥5% | % Lost ≥10% |
|---|---|---|---|
| 1 mg/weekly | -8.7% | 74% | 33% |
| 4 mg/weekly | -17.1% | 91% | 67% |
| 8 mg/weekly | -22.8% | 100% | 88% |
| 12 mg/weekly | -24.2% | 100% | 93% |
Important Notes
- Administered once weekly via subcutaneous injection
- Can be administered at any time of day, with or without meals
- Dose must be increased gradually to minimize side effects
- Maximum recommended dose: 12 mg/week
- If a dose is missed, administer within 5 days or skip and resume schedule
- Most common side effects: nausea (45%), vomiting (19%), constipation (16%), diarrhea (15%)
- Contraindications: pregnancy, lactation, history of thyroid cancer
- Female-specific: pregnancy test may be required before starting; hormonal contraception timing should be reviewed with clinician
Reconstitution Calculator
Calculate how much bacteriostatic water to add and how many units to draw on your syringe for your retatrutide dose.
Enter values and click Calculate
How Reconstitution Works
- Determine concentration: Divide peptide amount by water volume (e.g., 5 mg ÷ 2 mL = 2.5 mg/mL)
- Calculate draw volume: Divide your dose by concentration (e.g., 2 mg ÷ 2.5 mg/mL = 0.8 mL)
- Convert to syringe units: Multiply mL by 100 for U-100 syringes (0.8 mL = 80U)
- Verify syringe capacity: Ensure the draw volume fits your syringe
Example Calculation
Vial: 5 mg retatrutide
Water: 2 mL bacteriostatic
Dose: 2 mg
Syringe: 100U (1 mL)
Concentration: 5 mg ÷ 2 mL = 2.5 mg/mL
Draw volume: 2 mg ÷ 2.5 mg/mL = 0.8 mL = 80U on a U-100 syringe
What should a retatrutide dosage calculator do?
A retatrutide dosage calculator should only translate a dose that has already been provided by a qualified prescriber, trial protocol, or authorized clinical team. It should not recommend a starting dose, escalation plan, maintenance dose, or weight-loss target on its own. In clinical research, retatrutide has been studied as a once-weekly injectable GIP, GLP-1, and glucagon receptor agonist, and phase 2 obesity data reported dose-related gastrointestinal side effects and heart-rate changes, which is why unsupervised dosing is not a casual math problem.
Use any retatrutide dosage calculator for weight loss with three goals in mind: confirm the written dose, understand the injection volume, and prepare better questions for your healthcare professional. If the calculator gives a result that conflicts with your prescription, vial label, study instructions, or medical advice, stop and clarify before proceeding.
Step 1: Confirm whether retatrutide is appropriate to calculate at all
Before entering numbers, confirm the source of the medication and the source of the dose. In the United States, FDA warnings have noted that some companies have illegally sold unapproved products containing semaglutide, tirzepatide, or retatrutide, including products marketed with "research" language. The FDA has also stated in warning letters that there were no FDA-approved applications on file for certain compounded retatrutide products.
That matters because a calculator cannot verify purity, sterility, concentration, labeling accuracy, or whether a product should be used by a specific person. If retatrutide is being used in a clinical trial, follow the trial team's instructions exactly. If it is being discussed outside a trial, ask a licensed clinician whether there is a safer, approved option for your situation.
A quick pre-calculation check should include:
- The dose came from a licensed clinician or formal trial protocol.
- The medication source is legitimate and documented.
- The concentration is clearly written in mg/mL or another unambiguous format.
- You know the injection frequency, route, and timing.
- You have been told what side effects require medical attention.
- You are not using the calculator to design your own escalation schedule.
Step 2: Gather the exact inputs before calculating
A reliable retatrutide dosage calculator depends on clean inputs. Small wording differences can change the result, especially when converting milligrams to milliliters or syringe units. Do not estimate from memory, screenshots, forum posts, or someone else's plan.
Collect these details in one place:
- Prescribed dose in milligrams. This is the amount of retatrutide your clinician or protocol says should be taken at one dosing time.
- Medication concentration. This is usually written as mg/mL. For example, a concentration tells you how many milligrams are contained in each milliliter of liquid.
- Injection frequency. Retatrutide has been studied as once-weekly in obesity trials, but your own instructions must come from your authorized medical source.
- Syringe or pen format. A prefilled device may not require volume math, while a vial-and-syringe setup may require a measured volume.
- Patient-specific cautions. Pregnancy status, breastfeeding, gallbladder history, pancreatitis history, diabetes medications, kidney issues, and other conditions should be reviewed by a clinician, not handled by a calculator.
If any input is missing, the correct next step is not to "try a common dose." The correct next step is to pause and ask for written clarification.
Step 3: Convert milligrams to injection volume
Once you have a clinician-provided dose and a clearly labeled concentration, the basic calculator formula is straightforward:
Injection volume in mL = dose in mg ÷ concentration in mg/mL
For example, if a clinician-provided dose were 2 mg and the verified concentration were 10 mg/mL, the calculated injection volume would be 0.2 mL. This example is only a math demonstration, not a dosing recommendation. The dose, concentration, and product source must be verified for your specific situation.
If your syringe uses "units," remember that many U-100 insulin syringes represent 100 units per 1 mL. In that syringe format, 0.2 mL equals 20 units. However, syringe markings vary, and some devices should not be used interchangeably, so confirm the exact device with a pharmacist or clinician before relying on unit conversion.
Use this checklist before accepting the calculator result:
- The calculated mL amount looks physically measurable on your syringe or device.
- The result has not been rounded so aggressively that accuracy is lost.
- The concentration used in the calculator matches the label exactly.
- The dose was not confused with weekly total, per-injection amount, or maintenance target.
- The calculation has been checked by a clinician, pharmacist, or trial staff member when there is any uncertainty.
Step 4: Build in escalation and timing safeguards
Many injectable weight-management medications use gradual dose escalation to improve tolerability, but retatrutide does not have an FDA-approved public dosing schedule. In the phase 2 obesity trial, gastrointestinal adverse events were common, dose-related, and mostly mild to moderate, and the researchers noted that a lower starting dose partly mitigated those events. That finding supports the general safety principle that escalation should be medically supervised, not improvised.
If your instructions include an escalation schedule, enter each step separately rather than changing numbers in your head. Label each entry with the calendar week, dose, concentration, calculated volume, and who authorized the change. This creates a simple audit trail and helps prevent accidental jumps.
A safe tracking format can include:
- Week number or date range. Record the planned injection date, not just "week 3."
- Authorized dose. Copy the written dose exactly.
- Calculated volume. Write the mL amount and, if relevant, syringe units.
- Symptoms after the prior dose. Note nausea, vomiting, abdominal pain, dizziness, palpitations, constipation, diarrhea, or appetite changes.
- Decision before increasing. Confirm whether your clinician told you to increase, hold, reduce, or stop.
Never escalate simply because weight loss feels slow. Dose changes should account for side effects, health conditions, other medications, and the medical plan.
Is a retatrutide dosage calculator different for females?
A retatrutide dosage calculator female users search for should not assume that women need a separate automatic formula. Medication decisions may be influenced by body size, pregnancy potential, breastfeeding, hormone-related conditions, other prescriptions, and individual risk factors, but those are clinical considerations rather than a simple "female dose" toggle.
If you are female, ask specifically about pregnancy planning, contraception, breastfeeding, menstrual changes, gallbladder symptoms, and interactions with other medications. Weight-loss medications can also affect appetite, hydration, and gastrointestinal tolerance, which may influence how you feel week to week. A calculator can organize numbers, but it cannot evaluate reproductive health, diagnose side effects, or decide whether treatment is appropriate.
For best results, make the calculator gender-aware in the notes section rather than in the formula. Add relevant clinician-reviewed context, such as "pregnancy test required," "avoid if trying to conceive," or "review oral medication timing," only when those instructions come from your healthcare professional.
Step 5: Review red flags before every dose
Before each scheduled injection, compare how you feel with the safety instructions you were given. Retatrutide research has reported gastrointestinal adverse events and heart-rate changes, and longer-term safety continues to be evaluated through clinical development. Current phase 3 trials are designed to study efficacy and safety in people with obesity or overweight, including specific related conditions such as obstructive sleep apnea and knee osteoarthritis.
Pause and contact a healthcare professional promptly if you have symptoms that your care team identified as serious. These may include severe or persistent abdominal pain, repeated vomiting, dehydration, fainting, allergic-type symptoms, unusual heart symptoms, or signs of low blood sugar if you use diabetes medications. When in doubt, do not "calculate around" a symptom by lowering or splitting a dose without medical advice.
Also avoid these common calculator mistakes:
- Using someone else's vial concentration to calculate your dose.
- Confusing mg with mL.
- Assuming "units" always means the same thing across devices.
- Reusing an old calculation after the concentration changes.
- Taking extra medication after a missed dose without written instructions.
- Combining retatrutide with other weight-loss injections without clinician oversight.
Step 6: Document the result and verify it before use
The final step is to write down the result in plain language. A useful entry might say: "Authorized dose: __ mg. Concentration: __ mg/mL. Calculated volume: __ mL. Device marking: __ units. Injection date: __. Verified by: __." Leaving blanks until you have confirmed information is safer than filling them with guesses.
If you use an online retatrutide dosage calculator, keep a screenshot or printed copy with the inputs visible, not just the final answer. That makes it easier for a pharmacist, clinician, or trial coordinator to catch a wrong concentration or misplaced decimal. Recheck the calculation every time a new vial, pen, syringe, or instruction sheet is introduced.
Use the calculator as a safety tool, not a shortcut
A retatrutide dosage calculator can help reduce math errors when the dose and product details are already medically verified. It cannot determine whether retatrutide is safe for you, replace an approved prescribing label, or override a clinical trial protocol. Because retatrutide is still investigational and not FDA-approved, the safest approach is to use calculator results only as a conversation aid with a qualified healthcare professional.
If you are considering retatrutide for weight loss, start with a medical visit rather than a dosage calculator. Bring your weight history, current medications, lab results if available, prior weight-loss treatments, and any side effects from similar drugs. The best calculator is the one used inside a real care plan, with verified inputs and a clinician ready to help interpret the result.